NTMed
Magical Wound Healing Compounds
Startup Seed Health Tech & Life Sciences Est. 2020
Total Raised
$800K
Seed
Last Round
$800K
1 rounds
Team
3
1-10 employees
Confidence
76/100
Patents
1
About
Chronic, non-healing wounds impact millions, generating overall cost projections exceeding $100 billion, including costs for infection management, among which surgical wounds and diabetic ulcers were the most expensive to treat. Wound healing is a complex, dynamic cellular-based process supported by a myriad of cellular events that must be tightly coordinated to efficiently repair damaged tissue. Electric fields at wounds play a major role in wound healing and regenerative processes, with possible mechanisms involving regulation of cell migration, cell differentiation, and tissue growth. NTMed is developing the first and only materials combining: Electrical exogenous stimulus enhancing healing processes, Best antimicrobial efficacy, and highest safety profile.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Core Technology
Materials & SubstancesBiologicals
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B2C
Tags
nanotechnologypharmaceuticalsbiomaterials
Funding & Events
Jan 2020
Seed $800K
Details
Product Stage
R&D
Employees
1-10
Exact Count
4
Founded
2020
Locations
North District, Israel
Links
LinkedIn
Admin
Last Update
Nov 2, 2023
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
sector, homepage, video or image, news, markets, not claimed
Team (3)
Valery Diamant
Co-Founder
Founder
Marat Lerner
Co-Founder
Founder
Gideon Meiry
Co-Founder
Founder
Internal
Created by
Gideon Meiry (gmeiry@gmail.com)
Created
2023-10-03T00:00:00.000Z